In the health care industry theyre changing consumer expectations for how to lose weight, the timeliness of weight loss and the types of providers offering weight management support. There are more than 100 GLP-1 drugs in the development stages, and researchers are looking at using them for a variety of indications far beyond weight loss or diabetes control
FIGURE 7 High-performance liquid chromatography analysis showed that BSO treatment led to a 94 and 96% reduction in GSH and hGSH content, respectively, in wild-type roots with nodules (Supplementary Table 4)
In June 2024, researchers at Childrens Hospital of Philadelphia (CHOP) revealed mechanisms behind a molecules role in regulating insulin sensitivity, potentially paving the way for a new therapeutic target for obesity-related type 2 diabetes
MemelinkRGPasmanWJBongersATumpAvan GinkelATrompWet al
People with cardiovascular, renal or thyroid disease, those taking chronic medication or those who have had previous reactions to supplements
T.ChenY.et al (2022)